Huijbers, M. G., Vergoossen, D. L., Fillié-Grijpma, Y. E., van Es, I. E., Koning, M. T., Slot, L. M., . . . Verschuuren, J. J. (2019). MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity. Neurol Neuroimmunol Neuroinflamm.
Citação norma ChicagoHuijbers, Maartje G., et al. "MuSK Myasthenia Gravis Monoclonal Antibodies: Valency Dictates Pathogenicity." Neurol Neuroimmunol Neuroinflamm 2019.
ציטוט MLAHuijbers, Maartje G., et al. "MuSK Myasthenia Gravis Monoclonal Antibodies: Valency Dictates Pathogenicity." Neurol Neuroimmunol Neuroinflamm 2019.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.